
|Articles|March 10, 2008
Latebreakers: Dual anti-cholesterol niacin/statin combo granted approval
NiaSpan and simvastatin combination approved for cholesterol lowering.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
Lower Baseline BMI Predicts Weight Loss At 6 Months With Liraglutide
2
Providers, Patients Show Favorable Perception of Remdesivir During COVID-19 Pandemic
3
How the Delinking Model Can Drive Transparency, Avoid PBM Manipulation | NCPA 2025
4


























































































































































